TY - JOUR AU - Lauer, G. M. AU - Walker, B. D. PY - 2001 DA - 2001// TI - Hepatitis C virus infection JO - New England Journal of Medicine VL - 345 UR - https://doi.org/10.1056/NEJM200107053450107 DO - 10.1056/NEJM200107053450107 ID - Lauer2001 ER - TY - JOUR PY - 1999 DA - 1999// TI - Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium JO - J Viral Hepat VL - 6 UR - https://doi.org/10.1046/j.1365-2893.1999.6120139.x DO - 10.1046/j.1365-2893.1999.6120139.x ID - ref2 ER - TY - JOUR PY - 1999 DA - 1999// TI - EASL International Consensus Conference on hepatitis C. Paris, 26–27 February 1999. Consensus statement JO - J Hepatol VL - 31 ID - ref3 ER - TY - JOUR AU - Alter, H. J. AU - Seeff, L. B. PY - 2000 DA - 2000// TI - Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome JO - Seminars in Liver Disease VL - 20 UR - https://doi.org/10.1055/s-2000-9505 DO - 10.1055/s-2000-9505 ID - Alter2000 ER - TY - CHAP PY - 2002 DA - 2002// BT - Hepatitis C PB - Geneva CY - Switzerland ID - ref5 ER - TY - JOUR AU - Alberti, A. AU - Noventa, F. AU - Benvegnu, L. AU - Boccato, S. AU - Gatta, A. PY - 2002 DA - 2002// TI - Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection[summary for patients in Ann Intern Med. 2002 Dec 17;137(12):I36; PMID: 12484740] JO - Annals of Internal Medicine VL - 137 UR - https://doi.org/10.7326/0003-4819-137-12-200212170-00009 DO - 10.7326/0003-4819-137-12-200212170-00009 ID - Alberti2002 ER - TY - CHAP PY - 2007 DA - 2007// BT - HCV Infection in Europe ID - ref7 ER - TY - JOUR AU - Miro, J. M. AU - Laguno, M. AU - Moreno, A. AU - Rimola, A. PY - 2006 DA - 2006// TI - Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? JO - J Hepatol VL - 44 UR - https://doi.org/10.1016/j.jhep.2005.11.028 DO - 10.1016/j.jhep.2005.11.028 ID - Miro2006 ER - TY - CHAP AU - Brady, B. AU - Siebert, U. AU - Sroczynski, G. AU - Murphy, G. AU - Husereau, D. R. AU - Sherman, M. AU - Wong, W. AU - Mensinkai, S. PY - 2007 DA - 2007// BT - Pegylated Interferon combined with Ribavirin for chronic hepatitis C virus infection: an economic evaluation [Technology report no 82] PB - Canadian Agency for Drugs andTechnologies in Health (CADTH) CY - Ottawa, Canada ID - Brady2007 ER - TY - JOUR AU - Fried, M. W. AU - Shiffman, M. L. AU - Reddy, K. R. AU - Smith, C. AU - Marinos, G. AU - Goncales, F. L. AU - Haussinger, D. AU - Diago, M. AU - Carosi, G. AU - Dhumeaux, D. PY - 2002 DA - 2002// TI - Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa020047 DO - 10.1056/NEJMoa020047 ID - Fried2002 ER - TY - JOUR AU - Friedrich-Rust, M. AU - Zeuzem, S. AU - Sarrazin, C. PY - 2007 DA - 2007// TI - Current therapy for hepatitis C JO - Int J Colorectal Dis VL - 22 UR - https://doi.org/10.1007/s00384-005-0038-9 DO - 10.1007/s00384-005-0038-9 ID - Friedrich-Rust2007 ER - TY - JOUR AU - Hadziyannis, S. J. AU - Sette, H. AU - Morgan, T. R. AU - Balan, V. AU - Diago, M. AU - Marcellin, P. AU - Ramadori, G. AU - Bodenheimer, H. AU - Bernstein, D. AU - Rizzetto, M. PY - 2004 DA - 2004// TI - Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose JO - Ann Intern Med VL - 140 UR - https://doi.org/10.7326/0003-4819-140-5-200403020-00010 DO - 10.7326/0003-4819-140-5-200403020-00010 ID - Hadziyannis2004 ER - TY - JOUR AU - Manns, M. P. AU - McHutchison, J. G. AU - Gordon, S. C. AU - Rustgi, V. K. AU - Shiffman, M. AU - Reindollar, R. AU - Goodman, Z. D. AU - Koury, K. AU - Ling, M. AU - Albrecht, J. K. PY - 2001 DA - 2001// TI - Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)06102-5 DO - 10.1016/S0140-6736(01)06102-5 ID - Manns2001 ER - TY - JOUR AU - Wong, J. B. PY - 2006 DA - 2006// TI - Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies JO - Pharmacoeconomics VL - 24 UR - https://doi.org/10.2165/00019053-200624070-00005 DO - 10.2165/00019053-200624070-00005 ID - Wong2006 ER - TY - CHAP PY - 2001 DA - 2001// TI - Hepatitis C assays: Operational characteristics (Phase I) BT - Blood safety and clinical technology PB - Geneva CY - Switzerland ID - ref15 ER - TY - JOUR AU - Buti, M. AU - San Miguel, R. AU - Brosa, M. AU - Cabases, J. M. AU - Medina, M. AU - Angel Casado, M. AU - Fosbrook, L. AU - Esteban, R. PY - 2005 DA - 2005// TI - Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C JO - J Hepatol VL - 42 UR - https://doi.org/10.1016/j.jhep.2004.12.031 DO - 10.1016/j.jhep.2004.12.031 ID - Buti2005 ER - TY - JOUR AU - Davis, G. L. AU - Albright, J. E. AU - Cook, S. F. AU - Rosenberg, D. M. PY - 2003 DA - 2003// TI - Projecting future complications of chronic hepatitis C in the United States JO - Liver Transpl VL - 9 UR - https://doi.org/10.1053/jlts.2003.50073 DO - 10.1053/jlts.2003.50073 ID - Davis2003 ER - TY - JOUR AU - Deuffic, S. AU - Buffat, L. AU - Poynard, T. AU - Valleron, A. J. PY - 1999 DA - 1999// TI - Modeling the hepatitis C virus epidemic in France JO - Hepatology VL - 29 UR - https://doi.org/10.1002/hep.510290528 DO - 10.1002/hep.510290528 ID - Deuffic1999 ER - TY - JOUR AU - Sagmeister, M. AU - Renner, E. L. AU - Mullhaupt, B. AU - Wong, J. B. PY - 2002 DA - 2002// TI - Simulation of hepatitis C based on a mandatory reporting system JO - Eur J Gastroenterol Hepatol VL - 14 UR - https://doi.org/10.1097/00042737-200201000-00006 DO - 10.1097/00042737-200201000-00006 ID - Sagmeister2002 ER - TY - JOUR AU - Wong, J. B. AU - McQuillan, G. M. AU - McHutchison, J. G. AU - Poynard, T. PY - 2000 DA - 2000// TI - Estimating future hepatitis C morbidity, mortality, and costs in the United States JO - Am J Public Health VL - 90 UR - https://doi.org/10.2105/AJPH.90.10.1562 DO - 10.2105/AJPH.90.10.1562 ID - Wong2000 ER - TY - JOUR AU - Zou, S. AU - Tepper, M. AU - El Saadany, S. PY - 2000 DA - 2000// TI - Prediction of hepatitis C burden in Canada JO - Can J Gastroenterol VL - 14 UR - https://doi.org/10.1155/2000/642707 DO - 10.1155/2000/642707 ID - Zou2000 ER - TY - JOUR AU - Esteban, J. I. AU - Sauleda, S. AU - Quer, J. PY - 2008 DA - 2008// TI - The changing epidemiology of hepatitis C virus infection in Europe JO - J Hepatol VL - 48 UR - https://doi.org/10.1016/j.jhep.2007.07.033 DO - 10.1016/j.jhep.2007.07.033 ID - Esteban2008 ER - TY - BOOK PY - 2004 DA - 2004// TI - Hepatitis C and injecting drug use: impact, costs and policy options. Monograph 7 PB - European Monitoring Centre for Drugs and Drug Addiction CY - Lisbon ID - ref23 ER - TY - BOOK PY - 2008 DA - 2008// TI - Annual report 2008: the state of the drugs problem in Europe PB - Office for Official Publications of the European Communities CY - Luxembourg ID - ref24 ER - TY - CHAP PY - 1999 DA - 1999// BT - Hepatitis C ID - ref25 ER - TY - JOUR PY - 2002 DA - 2002// TI - National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002–June 10-12, 2002 JO - Hepatology VL - 36 ID - ref26 ER - TY - JOUR PY - 2004 DA - 2004// TI - Global burden of disease (GBD) for hepatitis C JO - J Clin Pharmacol VL - 44 UR - https://doi.org/10.1177/0091270003258669 DO - 10.1177/0091270003258669 ID - ref27 ER - TY - CHAP PY - 2006 DA - 2006// BT - WHO Regional Office for Europe: Country information ID - ref28 ER - TY - JOUR AU - Perz, J. F. AU - Armstrong, G. L. AU - Farrington, L. A. AU - Hutin, Y. J. AU - Bell, B. P. PY - 2006 DA - 2006// TI - The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide JO - J Hepatol VL - 45 UR - https://doi.org/10.1016/j.jhep.2006.05.013 DO - 10.1016/j.jhep.2006.05.013 ID - Perz2006 ER - TY - JOUR AU - Parkin, D. M. PY - 2006 DA - 2006// TI - The global health burden of infection-associated cancers in the year 2002 JO - Int J Cancer VL - 118 UR - https://doi.org/10.1002/ijc.21731 DO - 10.1002/ijc.21731 ID - Parkin2006 ER - TY - STD TI - Global Burden of Disease and Risk Factors. 2006, New York: Oxford University Press ID - ref31 ER - TY - JOUR AU - Murray, C. J. PY - 1994 DA - 1994// TI - Quantifying the burden of disease: the technical basis for disability-adjusted life years JO - Bull World Health Organ VL - 72 ID - Murray1994 ER - TY - JOUR AU - Murray, C. J. AU - Lopez, A. D. PY - 1994 DA - 1994// TI - Quantifying disability: data, methods and results JO - Bull World Health Organ VL - 72 ID - Murray1994 ER - TY - JOUR AU - Murray, C. J. AU - Lopez, A. D. PY - 1997 DA - 1997// TI - The utility of DALYs for public health policy and research: a reply JO - Bull World Health Organ VL - 75 ID - Murray1997 ER - TY - CHAP AU - Mathers, C. D. AU - Bernard, C. AU - Iburg, K. M. AU - Inoue, M. AU - Ma Fat, D. AU - Shibuya, K. AU - Stein, C. AU - Tomijima, N. PY - 2003 DA - 2003// TI - Global Burden of Disease in 2002: data sources, methods and results BT - GPE Discussion Paper No 54 PB - World Health Organization CY - Geneva, Switzerland ID - Mathers2003 ER - TY - JOUR AU - Sassi, F. PY - 2006 DA - 2006// TI - Calculating QALYs, comparing QALY and DALY calculations JO - Health Policy Plan VL - 21 UR - https://doi.org/10.1093/heapol/czl018 DO - 10.1093/heapol/czl018 ID - Sassi2006 ER - TY - CHAP PY - 2006 DA - 2006// BT - WHO Health for all database ID - ref37 ER - TY - JOUR PY - 1997 DA - 1997// TI - Hepatitis C: global prevalence JO - Wkly Epidemiol Rec VL - 72 ID - ref38 ER - TY - JOUR PY - 1999 DA - 1999// TI - Hepatitis C–global prevalence (update) JO - Wkly Epidemiol Rec VL - 74 ID - ref39 ER - TY - JOUR AU - Touzet, S. AU - Kraemer, L. AU - Colin, C. AU - Pradat, P. AU - Lanoir, D. AU - Bailly, F. AU - Coppola, R. C. AU - Sauleda, S. AU - Thursz, M. R. AU - Tillmann, H. PY - 2000 DA - 2000// TI - Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research JO - European Journal of Gastroenterology & Hepatology VL - 12 UR - https://doi.org/10.1097/00042737-200012060-00017 DO - 10.1097/00042737-200012060-00017 ID - Touzet2000 ER - TY - JOUR AU - Freeman, J. AU - Hutchison, G. B. PY - 1980 DA - 1980// TI - Prevalence, incidence and duration JO - Am J Epidemiol VL - 112 ID - Freeman1980 ER - TY - BOOK AU - MacMahon, B. AU - Trichopoulos, D. PY - 1996 DA - 1996// TI - Epidemiology – Principles and Methods PB - Little, Brown and Company CY - Boston, New York, Toronto, London ID - MacMahon1996 ER - TY - STD TI - World Health Organization: The Global Burden of Disease project: results for 2002 and earlier years, methods, documentation and publications. Manuals, resources and software for carrying out national burden of disease studies. [http://www.who.int/healthinfo/bodproject/en/index.html] UR - http://www.who.int/healthinfo/bodproject/en/index.html ID - ref43 ER - TY - CHAP PY - 2004 DA - 2004// BT - Mortality and burden of disease estimates for WHO member states in 2002 ID - ref44 ER - TY - CHAP PY - 2004 DA - 2004// BT - Estimates of Years Lost due to Disability by sex, cause and WHO Region for 2002 ID - ref45 ER - TY - JOUR PY - 2005 DA - 2005// TI - International Figures on organ donation and transplantation – 2004 JO - Newsletter Transplant VL - 10 ID - ref46 ER - TY - JOUR AU - Adam, R. AU - McMaster, P. AU - O'Grady, J. G. AU - Castaing, D. AU - Klempnauer, J. L. AU - Jamieson, N. AU - Neuhaus, P. AU - Lerut, J. AU - Salizzoni, M. AU - Pollard, S. PY - 2003 DA - 2003// TI - Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry JO - Liver Transpl VL - 9 UR - https://doi.org/10.1016/j.lts.2003.09.018 DO - 10.1016/j.lts.2003.09.018 ID - Adam2003 ER - TY - BOOK PY - 2007 DA - 2007// TI - Annual epidemiological report on communicable diseases in Europe ID - ref48 ER - TY - STD TI - Rantala M, Laar van de MJ: Surveillance and epidemiology of hepatitis B and C in Europe – a review. Euro Surveill. 2008, 13 (21): ID - ref49 ER - TY - CHAP PY - 2002 DA - 2002// TI - European Health Report BT - WHO Regional Publications, European Series PB - WHO Regional Office for Europe CY - Copenhagen, Denmark ID - ref50 ER - TY - JOUR AU - Desenclos, J. C. PY - 2003 DA - 2003// TI - The challenge of hepatitis C surveillance in Europe JO - Euro Surveill VL - 8 ID - Desenclos2003 ER - TY - STD TI - Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2005. [http://rki.de] UR - http://rki.de ID - ref52 ER - TY - JOUR AU - Arita, I. AU - Nakane, M. AU - Kojima, K. AU - Yoshihara, N. AU - Nakano, T. AU - El-Gohary, A. PY - 2004 DA - 2004// TI - Role of a sentinel surveillance system in the context of global surveillance of infectious diseases JO - Lancet Infect Dis VL - 4 UR - https://doi.org/10.1016/S1473-3099(04)00942-9 DO - 10.1016/S1473-3099(04)00942-9 ID - Arita2004 ER - TY - JOUR AU - Netesov, S. V. AU - Conrad, J. L. PY - 2001 DA - 2001// TI - Emerging infectious diseases in Russia JO - Emerging Infectious Diseases VL - 7 UR - https://doi.org/10.3201/eid0701.010101 DO - 10.3201/eid0701.010101 ID - Netesov2001 ER - TY - JOUR AU - Kim, W. R. PY - 2002 DA - 2002// TI - Global epidemiology and burden of hepatitis C JO - Microbes and Infection VL - 4 UR - https://doi.org/10.1016/S1286-4579(02)01649-0 DO - 10.1016/S1286-4579(02)01649-0 ID - Kim2002 ER - TY - CHAP PY - 2000 DA - 2000// BT - Guidelines for Second Generation HIV Surveillance for HIV: The Next Decade (2000) ID - ref56 ER - TY - JOUR AU - Mazurek, J. AU - Hutin, Y. AU - McNutt, L. A. AU - Morse, D. L. PY - 2002 DA - 2002// TI - Evaluation of hepatitis C surveillance in Poland in 1998 JO - Epidemiol Infect VL - 129 UR - https://doi.org/10.1017/S0950268802007124 DO - 10.1017/S0950268802007124 ID - Mazurek2002 ER - TY - CHAP PY - 2002 DA - 2002// BT - EUROSTAT Jahrbuch. Der statistische Wegweiser durch Europa PB - Europäische Kommission. Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften CY - Luxembourg ID - ref58 ER - TY - JOUR AU - Sy, T. AU - Jamal, M. M. PY - 2006 DA - 2006// TI - Epidemiology of hepatitis C virus (HCV) infection JO - Int J Med Sci VL - 3 UR - https://doi.org/10.7150/ijms.3.41 DO - 10.7150/ijms.3.41 ID - Sy2006 ER - TY - CHAP AU - Edlin, B. R. PY - 2005 DA - 2005// TI - Five million Americans infected with hepatitis C virus: a corrected estimate [abstract #44] BT - Oral Presentation at the 56th Annual Meeting of the American Association for the Study of Liver Diseases: 2005 PB - Hepatology CY - Boston, MA, USA ID - Edlin2005 ER - TY - JOUR AU - Edlin, B. R. AU - Carden, M. R. PY - 2006 DA - 2006// TI - Injection drug users: the overlooked core of the hepatitis C epidemic JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/499960 DO - 10.1086/499960 ID - Edlin2006 ER - TY - CHAP AU - Levitt, A. AU - Vorsters, A. AU - Emiroglu, N. AU - Goldstein, S. AU - Godal, T. AU - Kane, M. AU - Popovic, D. AU - Wiersma, S. AU - Van Damme, P. PY - 2004 DA - 2004// TI - Strengthening Immunisation Systems and Introduction of Hepatitis B Vaccine in Central and Eastern Europe and the Newly Independent States. Report of a meeting organised by the Centers for Disease Control and Prevention, Children's Vaccine Programme at the Programme for Appropriate Technology in Health, the Global Alliance for Vaccines and Immunisation, the United Nations Children's Fund, the Viral Hepatitis Prevention Board, and the World Health Organization BT - Kyiv, Ukraine ID - Levitt2004 ER - TY - CHAP PY - 2005 DA - 2005// BT - The UK vs. Europe: Losing the fight against hepatitis C ID - ref63 ER - TY - JOUR AU - Pradat, P. AU - Caillat-Vallet, E. AU - Sahajian, F. AU - Bailly, F. AU - Excler, G. AU - Sepetjan, M. AU - Trepo, C. AU - Fabry, J. AU - members, A. PY - 2001 DA - 2001// TI - Prevalence of hepatitis C infection among general practice patients in the Lyon area, France JO - European Journal of Epidemiology VL - 17 UR - https://doi.org/10.1023/A:1010902614443 DO - 10.1023/A:1010902614443 ID - Pradat2001 ER - TY - JOUR AU - Thierfelder, W. AU - Hellenbrand, W. AU - Meisel, H. AU - Schreier, E. AU - Dortschy, R. PY - 2001 DA - 2001// TI - Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998 JO - European Journal of Epidemiology VL - 17 UR - https://doi.org/10.1023/A:1013792013184 DO - 10.1023/A:1013792013184 ID - Thierfelder2001 ER - TY - JOUR AU - Ansaldi, F. AU - Bruzzone, B. AU - Salmaso, S. AU - Rota, M. C. AU - Durando, P. AU - Gasparini, R. AU - Icardi, G. PY - 2005 DA - 2005// TI - Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy JO - Journal of Medical Virology VL - 76 UR - https://doi.org/10.1002/jmv.20376 DO - 10.1002/jmv.20376 ID - Ansaldi2005 ER - TY - JOUR AU - Riestra, S. AU - Fernandez, E. AU - Leiva, P. AU - Garcia, S. AU - Ocio, G. AU - Rodrigo, L. PY - 2001 DA - 2001// TI - Prevalence of hepatitis C virus infection in the general population of northern Spain[see comment] JO - European Journal of Gastroenterology & Hepatology VL - 13 UR - https://doi.org/10.1097/00042737-200105000-00003 DO - 10.1097/00042737-200105000-00003 ID - Riestra2001 ER - TY - JOUR AU - Balogun, M. A. AU - Ramsay, M. E. AU - Hesketh, L. M. AU - Andrews, N. AU - Osborne, K. P. AU - Gay, N. J. AU - Morgan-Capner, P. PY - 2002 DA - 2002// TI - The prevalence of hepatitis C in England and Wales JO - J Infect VL - 45 UR - https://doi.org/10.1053/jinf.2002.1059 DO - 10.1053/jinf.2002.1059 ID - Balogun2002 ER - TY - CHAP PY - 2004 DA - 2004// BT - Estimates of numbers of deaths by sex, cause and WHO Region for 2002 ID - ref69 ER - TY - JOUR AU - Murray, C. J. AU - Lopez, A. D. PY - 1997 DA - 1997// TI - Mortality by cause for eight regions of the world: Global Burden of Disease Study JO - Lancet VL - 349 UR - https://doi.org/10.1016/S0140-6736(96)07493-4 DO - 10.1016/S0140-6736(96)07493-4 ID - Murray1997 ER - TY - JOUR AU - Bosch, F. X. AU - Ribes, J. AU - Diaz, M. AU - Cleries, R. PY - 2004 DA - 2004// TI - Primary liver cancer: worldwide incidence and trends JO - Gastroenterology VL - 127 UR - https://doi.org/10.1053/j.gastro.2004.09.011 DO - 10.1053/j.gastro.2004.09.011 ID - Bosch2004 ER - TY - JOUR AU - Montalto, G. AU - Cervello, M. AU - Giannitrapani, L. AU - Dantona, F. AU - Terranova, A. AU - Castagnetta, L. A. PY - 2002 DA - 2002// TI - Epidemiology, risk factors, and natural history of hepatocellular carcinoma JO - Ann N Y Acad Sci VL - 963 UR - https://doi.org/10.1111/j.1749-6632.2002.tb04090.x DO - 10.1111/j.1749-6632.2002.tb04090.x ID - Montalto2002 ER - TY - JOUR AU - Sagnelli, E. AU - Stroffolini, T. AU - Mele, A. AU - Almasio, P. AU - Coppola, N. AU - Ferrigno, L. AU - Scolastico, C. AU - Onofrio, M. AU - Imparato, M. AU - Filippini, P. PY - 2005 DA - 2005// TI - The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases JO - Journal of Medical Virology VL - 75 UR - https://doi.org/10.1002/jmv.20313 DO - 10.1002/jmv.20313 ID - Sagnelli2005 ER - TY - JOUR AU - Stroffolini, T. AU - Stroffolini, T. PY - 2005 DA - 2005// TI - Etiological factor of hepatocellular carcinoma in Italy JO - Minerva Gastroenterologica e Dietologica VL - 51 ID - Stroffolini2005 ER - TY - JOUR AU - Peters, M. G. AU - Terrault, N. A. PY - 2002 DA - 2002// TI - Alcohol use and hepatitis C JO - Hepatology VL - 36 UR - https://doi.org/10.1002/hep.1840360728 DO - 10.1002/hep.1840360728 ID - Peters2002 ER - TY - JOUR AU - Shepard, C. W. AU - Finelli, L. AU - Alter, M. J. PY - 2005 DA - 2005// TI - Global epidemiology of hepatitis C virus infection JO - Lancet Infect Dis VL - 5 UR - https://doi.org/10.1016/S1473-3099(05)70216-4 DO - 10.1016/S1473-3099(05)70216-4 ID - Shepard2005 ER - TY - CHAP PY - 2004 DA - 2004// BT - Estimates of DALYs by sex, cause and WHO Region for 2002 ID - ref77 ER - TY - JOUR AU - Spiegel, B. M. AU - Younossi, Z. M. AU - Hays, R. D. AU - Revicki, D. AU - Robbins, S. AU - Kanwal, F. PY - 2005 DA - 2005// TI - Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment JO - Hepatology VL - 41 UR - https://doi.org/10.1002/hep.20659 DO - 10.1002/hep.20659 ID - Spiegel2005 ER - TY - JOUR AU - Foster, G. R. AU - Goldin, R. D. AU - Thomas, H. C. PY - 1998 DA - 1998// TI - Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis JO - Hepatology VL - 27 UR - https://doi.org/10.1002/hep.510270132 DO - 10.1002/hep.510270132 ID - Foster1998 ER - TY - JOUR AU - Lang, C. A. AU - Conrad, S. AU - Garrett, L. AU - Battistutta, D. AU - Cooksley, W. G. AU - Dunne, M. P. AU - Macdonald, G. A. PY - 2006 DA - 2006// TI - Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection JO - J Pain Symptom Manage VL - 31 UR - https://doi.org/10.1016/j.jpainsymman.2005.08.016 DO - 10.1016/j.jpainsymman.2005.08.016 ID - Lang2006 ER - TY - JOUR AU - Hollander, A. AU - Foster, G. R. AU - Weiland, O. PY - 2006 DA - 2006// TI - Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C JO - Scand J Gastroenterol VL - 41 UR - https://doi.org/10.1080/00365520500325952 DO - 10.1080/00365520500325952 ID - Hollander2006 ER - TY - JOUR AU - von Wagner, M. AU - Lee, J. H. AU - Kronenberger, B. AU - Friedl, R. AU - Sarrazin, C. AU - Teuber, G. AU - Herrmann, E. AU - Zeuzem, S. PY - 2006 DA - 2006// TI - Impaired health-related quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels JO - J Viral Hepat VL - 13 UR - https://doi.org/10.1111/j.1365-2893.2006.00772.x DO - 10.1111/j.1365-2893.2006.00772.x ID - von Wagner2006 ER - TY - BOOK AU - Siebert, U. AU - Sroczynski, G. PY - 2003 DA - 2003// TI - [Antiviral therapy for patients with chronic hepatitis C in Germany. Evaluation of effectiveness and cost-effectiveness of initial combination therapy with Interferon/Peginterferon plus Ribavirin. Series of the German Institute for Medical Documentation and Information commissioned by the Federal Ministry of Health and Social Security] PB - DIMDI CY - Köln ID - Siebert2003 ER - TY - JOUR AU - Siebert, U. AU - Sroczynski, G. PY - 2005 DA - 2005// TI - Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health and Social Security JO - Int J Technol Assess Health Care VL - 21 UR - https://doi.org/10.1017/S0266462305050075 DO - 10.1017/S0266462305050075 ID - Siebert2005 ER - TY - JOUR AU - Chong, C. A. AU - Gulamhussein, A. AU - Heathcote, E. J. AU - Lilly, L. AU - Sherman, M. AU - Naglie, G. AU - Krahn, M. PY - 2003 DA - 2003// TI - Health-state utilities and quality of life in hepatitis C patients JO - Am J Gastroenterol VL - 98 UR - https://doi.org/10.1111/j.1572-0241.2003.07332.x DO - 10.1111/j.1572-0241.2003.07332.x ID - Chong2003 ER - TY - CHAP AU - Siebert, U. AU - Ravens-Sieberer, U. AU - Greiner, W. AU - Sroczynski, G. AU - Wong, J. B. AU - Kuntz, K. M. AU - Kallinowski, B. AU - Graf von der Schulenburg, J. M. AU - Bullinger, M. AU - Rossol, S. ED - Kind, P. ED - Macran, S. PY - 2003 DA - 2003// TI - Performance of different utility assessment methods in chronic hepatitis C patients BT - Proceedings of the 19th Plenary Meeting of the EuroQol Group 13th-14th September 2002 Discussion Papers PB - Centre for Health Economics, University of York CY - York, UK ID - Siebert2003 ER - TY - CHAP AU - Mathers, C. D. PY - 2005 DA - 2005// BT - Uncertainty and data availability for the global burden of disease estimates 2000–2002 ID - Mathers2005 ER - TY - CHAP PY - 2006 DA - 2006// BT - Hepatitis C ID - ref88 ER - TY - JOUR AU - Wolff, M. AU - Kalff, J. C. AU - Schwarz, N. T. AU - Lauschke, H. AU - Minor, T. AU - Tolba, R. H. AU - Hirner, A. PY - 2003 DA - 2003// TI - [Liver transplantation in Germany] JO - Zentralbl Chir VL - 128 UR - https://doi.org/10.1055/s-2003-44344 DO - 10.1055/s-2003-44344 ID - Wolff2003 ER - TY - JOUR AU - Chen, S. L. AU - Morgan, T. R. PY - 2006 DA - 2006// TI - The natural history of hepatitis C virus (HCV) infection JO - Int J Med Sci VL - 3 UR - https://doi.org/10.7150/ijms.3.47 DO - 10.7150/ijms.3.47 ID - Chen2006 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/9/34/prepub UR - http://www.biomedcentral.com/1471-2458/9/34/prepub ID - ref91 ER -